See All Slides - tctmd.com

Slides

Presentation TCT 2012

Take Home Messages

Presenter: Harald Mudra

October 22, 2012

Presentation TCT 2012

How Clever of Me! (My Most Innovative Solution)

Presenter: Sundeep Mishra

October 24, 2012

Presentation TCT 2012

Case Exotica!

Presenter: Ajit Mullasari

October 24, 2012

Presentation TCT 2012

Might a Self-Expanding Stent have a Role in STEMI? Interim Results from APPOSITION III

Presenter: Harald Mudra

October 25, 2012

Presentation TCT 2013

Case presentation: Low Flow, Low Gradient Severe AS

Presenter: Ricardo Allende

October 30, 2013

Presentation TCT 2013

Case Presentation Conclusion: Procedural and Patient Outcomes

Presenter: Divaka Perera

October 30, 2013

Presentation TCT 2013

Problem Statement: The Good, the Bad, and the Ugly of Clinical Research in 2013

Presenter: Mitchell Krucoff

October 30, 2013

Presentation TCT 2013

The MitraClip Procedure: Imaging Guidance in the Cath Lab

Presenter: John Carroll

October 30, 2013

Presentation TCT 2013

Clinical Trial Alternatives for New LAA Occlusion Devices: For High-Risk AF Patients Who Are Tolerant to Anticoagulation or Poor Anticoagulation Candidates Due to Bleeding Risks...

Presenter: Brian Whisenant

October 30, 2013

Presentation TCT 2013

Lessons Learned from PARTNER 2A and SURTAVI: Device Specificity, Trial Design, Endpoints, and Future Low-risk Studies

Presenter: Jodi Akin

October 30, 2013

Advertisement

Slides

Take Home Messages

How Clever of Me! (My Most Innovative Solution)

Case Exotica!

Might a Self-Expanding Stent have a Role in STEMI? Interim Results from APPOSITION III

Case presentation: Low Flow, Low Gradient Severe AS

Case Presentation Conclusion: Procedural and Patient Outcomes

Problem Statement: The Good, the Bad, and the Ugly of Clinical Research in 2013

The MitraClip Procedure: Imaging Guidance in the Cath Lab

Clinical Trial Alternatives for New LAA Occlusion Devices: For High-Risk AF Patients Who Are Tolerant to Anticoagulation or Poor Anticoagulation Candidates Due to Bleeding Risks...

Lessons Learned from PARTNER 2A and SURTAVI: Device Specificity, Trial Design, Endpoints, and Future Low-risk Studies

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content